Thrombosis prophylaxis in visceral surgery with the low molecular weight heparin fragment Kabi 2165 (7,500 and 2,500 anti-Xa IU/day).
D000005:Abdomen / Q000601:surgery*; D002986:Clinical Trials as Topic; D005170:Factor X / Q000502:physiology; D015951:Factor Xa; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D011183:Postoperative Complications / Q000517:prevention & control*; D013927:Thrombosis / Q000188:drug therapy / Q000517:prevention & control*
D005170:Factor X; D006493:Heparin; D015951:Factor Xa